Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,676
Closed -$326K 3
2018
Q4
$326K Sell
1,676
-1,274
-43% -$249K 2.89% 11
2018
Q3
$612K Sell
2,950
-2,444
-45% -$482K 1.36% 16
2018
Q2
$996K Sell
5,394
-18,431
-77% -$3.26M 1.23% 13
2018
Q1
$4.06M Sell
23,825
-12,901
-35% -$2.37M 1.87% 2
2017
Q4
$6.39M Sell
36,726
-9,405
-20% -$1.66M 1.85% 3
2017
Q3
$8.6M Sell
46,131
-8,403
-15% -$1.49M 1.75% 1
2017
Q2
$9.39M Sell
54,534
-5,676
-9% -$923K 1.5% 2
2017
Q1
$9.88M Buy
60,210
+13,004
+28% +$2.16M 1.3% 7
2016
Q4
$6.9M Sell
47,206
-5,004
-10% -$753K 1% 10
2016
Q3
$8.71M Buy
52,210
+119
+0.2% +$20.1K 1.21% 4
2016
Q2
$7.93M Buy
+52,091
New +$8.1M 1.23% 4

Other funds holding AMGN

Nuveen Fund Advisors's AMGN Position: Q1 2019 in Review

Nuveen Fund Advisors sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,676 shares — an estimated $326K sold.

Nuveen Fund Advisors first reported a position in AMGN in Q2 2016 and held it in 11 quarters. The position peaked at $9.88M in Q1 2017. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Nuveen Fund Advisors reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Nuveen Fund Advisors sold 1,676 Amgen shares in Q1 2019, an estimated $326K.
  • Nuveen Fund Advisors first reported a position in Amgen in Q2 2016 and held it in 11 quarters.
  • Nuveen Fund Advisors's Amgen position peaked at $9.88M in Q1 2017.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Nuveen Fund Advisors's 13F filing for Q1 2019, filed 14 May 2019.